The effects of in vitro hemodilution with gelatin, hydroxyethyl starch, and lactated ringer's solution on markers of coagulation:: An analysis using SONOCLOT™

被引:33
作者
Konrad, C [1 ]
Markl, T
Schuepfer, G
Gerber, H
Tschopp, M
机构
[1] Kantonsspital, Dept Anesthesiol & Intens Care, CH-6000 Lucerne 16, Switzerland
[2] Kantonsspital, Hematol Labs, CH-6000 Lucerne, Switzerland
关键词
D O I
10.1097/00000539-199903000-00003
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Blood-saving strategies have recently been established to avoid allogeneic transfusion during surgery or after trauma. This includes an expanding use of crystalloids and colloids. These solutions interfere with coagulation systems, but quantitative measurements are still lacking. The SONOCLOT(TM) (Sienco Company, Morrison, CO) analysis (SCT), a viscoelastic test, measures clot formation and includes information on the cellular, as well as the plasmatic coagulation, system. To quantify hemodilutional effects on in vitro coagulation, we studied gelatin (G), hydroxyethyl starch 6% (HES; molecular weight 450,000), and lactated Ringer's solution (RL) in 33% and 66% dilutions measuring routines laboratory and SCT variables. Hemodilution with RL tended to increase in vitro coagulability. Among the tested colloids, G had the least impact on markers of coagulation. G33% did not differ significantly from the undiluted control group. HES had the largest impact on markers of coagulation compared with G and RL. In conclusion, SCT provides a fast and easy to perform bedside test to quantify in vitro hemodilution. Implications: The effects of progressive hemodilution on coagulation are difficult to measure. SONOCLOT analyses provide an easy to perform test with fast information on cellular and plasmatic coagulation properties. Among colloids, hydroxyethyl starch has the largest impact on markers of coagulation compared with gelatin or lactated Ringer's solution.
引用
收藏
页码:483 / 488
页数:6
相关论文
共 26 条
[1]   Determination of tumor cell procoagulant activity by Sonoclot(TM) analysis in whole blood [J].
Amirkhosravi, A ;
Biggerstaff, JP ;
Warnes, G ;
Francis, DA ;
Francis, JL .
THROMBOSIS RESEARCH, 1996, 84 (05) :323-332
[2]  
CHANDLER WL, 1986, CLIN CHEM, V32, P505
[3]  
CHAPIN JW, 1989, TRANSPLANT P, V21, P3539
[4]   Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation [J].
Egli, GA ;
Zollinger, A ;
Seifert, B ;
Popovic, D ;
Pasch, T ;
Spahn, DR .
BRITISH JOURNAL OF ANAESTHESIA, 1997, 78 (06) :684-689
[5]   AFFINITY OF FIBRONECTIN TO COLLAGENS OF DIFFERENT GENETIC TYPES AND TO FIBRINOGEN [J].
ENGVALL, E ;
RUOSLAHTI, E ;
MILLER, EJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 147 (06) :1584-1595
[6]   ASSESSMENT OF HYPERCOAGULABILITY IN PATIENTS WITH CANCER USING THE SONOCLOT-ANALYZER(TM) AND THROMBOELASTOGRAPHY [J].
FRANCIS, JL ;
FRANCIS, DA ;
GUNATHILAGAN, GJ .
THROMBOSIS RESEARCH, 1994, 74 (04) :335-346
[7]  
Hensel M, 1996, Anasthesiol Intensivmed Notfallmed Schmerzther, V31, P481, DOI 10.1055/s-2007-995963
[8]   SONOCLOT ANALYSIS [J].
HETT, DA ;
WALKER, D ;
PILKINGTON, SN ;
SMITH, DC .
BRITISH JOURNAL OF ANAESTHESIA, 1995, 75 (06) :771-776
[9]   ROLE OF THROMBOELASTOGRAPHY IN BLEEDING DIATHESES AND REGIONAL ANESTHESIA [J].
MALLETT, SV ;
PLATT, M .
LANCET, 1991, 338 (8769) :765-766
[10]   EFFECTS OF 6-PERCENT HYDROXYETHYL STARCH AND 3-PERCENT MODIFIED FLUID GELATIN ON INTRAVASCULAR VOLUME AND COAGULATION DURING INTRAOPERATIVE HEMODILUTION [J].
MORTELMANS, YJ ;
VERMAUT, G ;
VERBRUGGEN, AM ;
ARNOUT, JM ;
VERMYLEN, J ;
VANAKEN, H ;
MORTELMANS, LA .
ANESTHESIA AND ANALGESIA, 1995, 81 (06) :1235-1242